SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-563782
Filing Date
2016-04-28
Accepted
2016-04-28 16:23:10
Documents
4
Period of Report
2016-06-10
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d165506ddef14a.htm DEF 14A 470093
2 GRAPHIC g165506g35z34.jpg GRAPHIC 64431
3 GRAPHIC g165506pc01.jpg GRAPHIC 122645
4 GRAPHIC g165506pc02.jpg GRAPHIC 120330
  Complete submission text file 0001193125-16-563782.txt   894887
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37587 | Film No.: 161600418
SIC: 2834 Pharmaceutical Preparations